2025-05-08

Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 April 2025

2025-05-07

VOLUNTARY ANNOUNCEMENT - FURTHER PAYMENT RECEIVED UNDER THE LICENSE AND COLLABORATION AGREEMENT WITH AXION BIO FOR IMM2510 (PALVERAFUSP) AND IMM27M (TAZLESTOBART)

2025-05-06

VOLUNTARY ANNOUNCEMENT - APPOINTMENT OF CHIEF BUSINESS OFFICER

2025-04-30

Proxy Form for the Annual General Meeting to be held on May 28, 2025

2025-04-30

NOTICE OF THE ANNUAL GENERAL MEETING

2025-04-30

CIRCULAR OF THE 2024 ANNUAL GENERAL MEETING

2025-04-25

Annual Report 2024

2025-04-24

NSIDE INFORMATION - THE H SHARE FULL CIRCULATION LISTING APPROVAL GRANTED BY THE STOCK EXCHANGE

2025-04-03

Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 March 2025

2025-04-02

VOLUNTARY ANNOUNCEMENT - UPDATES ON THE CLINICAL TRIAL OF IMC-003/IMM72

2025-03-26

VOLUNTARY ANNOUNCEMENT - INCREASE IN SHAREHOLDING BY EXECUTIVE DIRECTOR, CHIEF EXECUTIVE OFFICER AND CHAIRMAN OF THE BOARD

2025-03-25

ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2024 AND PROPOSED CHANGE IN USE OF PROCEEDS

2025-03-14

INSIDE INFORMATION - ISSUANCE OF FILING NOTICE BY THE CSRC FOR THE H SHARE FULL CIRCULATION OF CERTAIN UNLISTED SHARES OF THE COMPANY

2025-03-13

DATE OF BOARD MEETING

2025-03-06

VOLUNTARY ANNOUNCEMENT - APPROVAL BY THE NMPA FOR CLINICAL TRIAL OF IMM01 (TIMDARPACEPT) COMBINED WITH IMM2510 (PALVERAFUSP) AND WITH OR WITHOUT CHEMOTHERAPY FOR ADVANCED MALIGNANT TUMORS

2025-03-05

Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 28 February 2025

2025-02-21

COMPLETION OF DISCLOSEABLE TRANSACTION - DISPOSAL OF EQUITY INTEREST IN A SUBSIDIARY

2025-02-17

(REVISED) SUPPLEMENTAL ANNOUNCEMENT - DISCLOSEABLE TRANSACTION IN RELATION TO THE DISPOSAL OF A SUBSIDIARY

2025-02-06

Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 January 2025

2025-01-24

ARTICLES OF ASSOCIATION